Literature DB >> 17278216

Usefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy.

Lukasz Liszka1, Ewa Zielińska-Pajak, Jacek Pajak, Dariusz Gołka, Jacek Starzewski, Zbigniew Lorenc.   

Abstract

AIM: To assess the usefulness of two independent histopathological classifications of rectal cancer regression following neo-adjuvant therapy.
METHODS: Forty patients at the initial stage cT3NxM0 submitted to preoperative radiotherapy (42 Gy during 18 d) and then to radical surgical treatment. The relationship between "T-downstaging" versus regressive changes expressed by tumor regression grade (TRG 1-5) and Nasierowska-Guttmejer classification (NG 1-3) was studied as well as the relationship between TRG and NG versus local tumor stage ypT and lymph nodes status, ypN.
RESULTS: Complete regression (ypT0, TRG 1) was found in one patient. "T-downstaging" was observed in 11 (27.5%) patients. There was a weak statistical significance of the relationship between "T-downstaging" and TRG staging and NG stage. Patients with ypT1 were diagnosed as TRG 2-3 while those with ypT3 as TRG5. No lymph node metastases were found in patients with TRG 1-2. None of the patients without lymph node metastases were diagnosed as TRG 5. Patients in the ypT1 stage were NG 1-2. No lymph node metastases were found in NG 1. There was a significant correlation between TRG and NG.
CONCLUSION: Histopathological classifications may be useful in the monitoring of the effects of hyperfractionated preoperative radiotherapy in patients with rectal cancer at the stage of cT3NxM0. There is no unequivocal relationship between "T-downstaging" and TRG and NG. There is some concordance in the assessment of lymph node status with ypT, TRG and NG. TRG and NG are of limited value for the risk assessment of the lymph node involvement.

Entities:  

Mesh:

Year:  2007        PMID: 17278216      PMCID: PMC4065972          DOI: 10.3748/wjg.v13.i4.524

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  71 in total

1.  Complete pathologic response after chemoradiation for rectal cancer.

Authors:  Margaret Henri; Jean-François Latulippe; Françoise Heyen; Serge Dubé
Journal:  Dis Colon Rectum       Date:  2005-05       Impact factor: 4.585

2.  Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience.

Authors:  N A Janjan; V S Khoo; J Abbruzzese; R Pazdur; R Dubrow; K R Cleary; P K Allen; P M Lynch; G Glober; R Wolff; T A Rich; J Skibber
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-15       Impact factor: 7.038

3.  Local excision of T2 and T3 rectal cancers after downstaging chemoradiation.

Authors:  C J Kim; T J Yeatman; D Coppola; A Trotti; B Williams; J S Barthel; W Dinwoodie; R C Karl; J Marcet
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

4.  Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer.

Authors:  Jose G Guillem; David B Chessin; Alfred M Cohen; Jinru Shia; Madhu Mazumdar; Warren Enker; Philip B Paty; Martin R Weiser; David Klimstra; Leonard Saltz; Bruce D Minsky; W Douglas Wong
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

5.  Distal cT2N0 rectal cancer: is there an alternative to abdominoperineal resection?

Authors:  Ramesh Rengan; Philip Paty; W Douglas Wong; Jose Guillem; Martin Weiser; Larissa Temple; Leonard Saltz; Bruce D Minsky
Journal:  J Clin Oncol       Date:  2005-08-01       Impact factor: 44.544

6.  Neoadjuvant therapy for rectal cancer down-stages the tumor but reduces lymph node harvest significantly.

Authors:  Ruwan E Wijesuriya; Kemal I Deen; Janaki Hewavisenthi; Jayantha Balawardana; Mahendra Perera
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

7.  Immediate radical resection after local excision of rectal cancer: an oncologic compromise?

Authors:  Dieter Hahnloser; Bruce G Wolff; David W Larson; Jennifer Ping; Santhat Nivatvongs
Journal:  Dis Colon Rectum       Date:  2005-03       Impact factor: 4.585

8.  Long-term results of preoperative radiotherapy for 113 cases of UT3 and UT4 rectal cancer: a need for long-term follow-up.

Authors:  V Moutardier; E Tardat; M Giovannini; B Lelong; J Guiramand; V Magnin; G Houvenaeghel; J R Delpero
Journal:  Dis Colon Rectum       Date:  2003-09       Impact factor: 4.585

9.  Preoperative hyperfractionated accelerated radiotherapy (HART) and concomitant CPT-11 in locally advanced rectal carcinoma: a phase I study.

Authors:  Verena Voelter; Roger Stupp; Maurice Matter; Michel Gillet; Hanifa Bouzourene; Serge Leyvraz; Philippe Coucke
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-08-01       Impact factor: 7.038

10.  Preoperative chemoradiation downstages locally advanced ultrasound-staged rectal cancer.

Authors:  P G Meade; G J Blatchford; A G Thorson; M A Christensen; C A Ternent
Journal:  Am J Surg       Date:  1995-12       Impact factor: 2.565

View more
  1 in total

1.  Neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART) combined with S-1 for locally advanced rectal cancer.

Authors:  Hiroshi Doi; Naohito Beppu; Soichi Odawara; Masao Tanooka; Yasuhiro Takada; Yasue Niwa; Masayuki Fujiwara; Fumihiko Kimura; Hidenori Yanagi; Naoki Yamanaka; Norihiko Kamikonya; Shozo Hirota
Journal:  J Radiat Res       Date:  2013-05-08       Impact factor: 2.724

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.